Back to ACAD

Ikarian Capital, LLC → ACAD

Ikarian Capital, LLC ACAD Position History

Acadia Pharmaceuticals Inc. • Healthcare

Quarters held
5
Latest value
$7.1M
Q3 2026
Peak value
$17.1M
First seen
Q1 2026

Dollar value over time

Show data table
PeriodPosition value
Q1 2026$625K
Q2 2026$711K
Q3 2026$2.3M
Q3 2026$17.1M
Q3 2026$7.1M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$7.1M350.0K——
Q3 2026$17.1M850.0K——
Q3 2026$2.3M112.0K——
Q2 2026$711K28.1K——
Q1 2026$625K28.1K——

Other funds holding ACAD

Other Ikarian Capital, LLC positions

KOD

KODIAK SCIENCES INC

$50.5M
KOD

KODIAK SCIENCES INC

$48.3M
AAVXF

ABIVAX SA

$43.4M
KOD

KODIAK SCIENCES INC

$41.3M
AAVXF

ABIVAX SA

$29.1M
AAVXF

ABIVAX SA

$28.4M
JAZZ

JAZZ PHARMACEUTICALS PLC

$27.3M
ALMS

ALUMIS INC

$26.7M